A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

This month marks a year since the malaria vaccine rollout began. Here's what we still need in order to beat a disease as old ...

With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

Novel anti-malaria antibodies have been identified, potentially contributing to the next generation of malaria prevention. Researchers at the National Institutes of Health (MD, USA) have identified a ...

The discovery of the pGlu-CSP epitope opens up new avenues for developing next-generation malaria vaccines and treatments.

More samples are on the way, WHO said. Provincial Health Minister Apollinaire Yumba told Reuters that anti-malaria medicine provided by WHO was being distributed in the main hospital and health ...

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

Augusta Cueva-Agila explains how the Cinchona officinalis, native to the Andean foothills, produced the world’s first anti-malarial drug ...

Cambodia has reported a 74 per cent decrease in malaria cases in 2024, marking significant progress in the fight against the ...

New antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody ...